A classroom reflecting life's diversity will benefit children of all strata while enriching teaching experience. Now that the Supreme Court has validated the Right to Education (RTE), its success will depend on teachers. When I said this to a friend who teaches in a primary school, she said, “you are being unfair.” I was startled to hear this response because what I had said was common sense. When I pointed this...

The country is clearly shaping its legislation to promote access to medicines by fostering generic production. INDIA'S approach to the revision of its Patents Act in 2005 is a clear example of a country shaping its legislation to promote access to medicines by fostering generic production. Although World Trade Organisation (WTO) rules made it mandatory for India to put in place a patent regime for medicines by 2005, nothing obliges...

The Supreme Court wanted to know today “what was happening” in the Orissa Maoist hostage crisis. The Centre told the court it had “no idea”, while the Orissa government — the primary respondent in a public interest petition seeking to prevent it from succumbing to the “blackmail tactics” of Maoists — was not represented. A Bench of Justices T S Thakur and Gyan Sudha Misra had posted an urgent hearing of...

-PTI The Centre today told Supreme Court that habitual offenders detained under special preventive detention laws cannot invoke the jurisdiction of the Right To Information(RTI) Act to know the grounds for the action against them. Appearing before a three-judge bench of justices Altamas Kabir, Gyan Sudha Mishra and J Chalameshwar, Additional Solictor General P P Malhotra said the RTI Act was not available to suspects as the legislation was subordinate to...

India is coming under increasing pressure from the U.S. and the European Union for the strict patentability criteria it applies for medicines. AS was only to be expected, the two landmark decisions made by the Indian patent office in recent times concerning pharmaceutical patent cases have not gone down well with the multinational drug industry. First, there was the rejection in 2006 of the patent application by the Swiss multinational...